Sanofi (ETR:SNW)
93.33
-0.07 (-0.07%)
Apr 24, 2025, 5:35 PM CET
Sanofi Revenue
Sanofi had revenue of 10.61B EUR in the quarter ending March 31, 2025, a decrease of -4.61%. This brings the company's revenue in the last twelve months to 45.17B, down -2.42% year-over-year. In the year 2024, Sanofi had annual revenue of 44.29B with 7.73% growth.
Revenue (ttm)
45.17B
Revenue Growth
-2.42%
P/S Ratio
2.53
Revenue / Employee
544.97K
Employees
82,878
Market Cap
114.13B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Bayer Aktiengesellschaft | 46.61B |
Sartorius Aktiengesellschaft | 3.44B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
Sanofi News
- 1 day ago - Novartis and Sanofi CEOs say EU should raise drug prices in face of tariffs - Reuters
- 1 day ago - Innate Pharma Regains Its Rights on CD123 Targeting ANKET and Announces Sanofi’s Intention to Make a Strategic Investment in the Company - Wallstreet:Online
- 6 days ago - Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition - Reuters
- 6 days ago - Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria - GlobeNewsWire
- 7 days ago - Earendil Labs and Sanofi partner for two bispecific antibodies - Seeking Alpha
- 9 days ago - Sanofi Asthma Drug Misses Primary Goal, Plans For Pivotal Study - Benzinga
- 9 days ago - Sanofi flunks mid-stage trial for asthma drug - Seeking Alpha
- 9 days ago - Press Release: Sanofi's respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD - Benzinga